{"version":"1.0","provider_name":"Brakke Consulting\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8","provider_url":"https:\/\/brakkeconsulting.com\/ja","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"70bUapCwhl\"><a href=\"https:\/\/brakkeconsulting.com\/ja\/animal-health-news-notes-for-september-6-2024\/\">2024 \u5e74 9 \u6708 6 \u65e5\u306e\u52d5\u7269\u306e\u5065\u5eb7\u306b\u95a2\u3059\u308b\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/ja\/animal-health-news-notes-for-september-6-2024\/embed\/#?secret=70bUapCwhl\" width=\"600\" height=\"338\" title=\"\u300c2024\u5e749\u67086\u65e5\u306e\u52d5\u7269\u885b\u751f\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8\u300d\u2014 Brakke Consulting\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8\" data-secret=\"70bUapCwhl\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for September 6, 2024 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Brakke Consulting News Transaction Insights Seminar \u2013 now virtual Other News Boehringer Ingelheim Comitis Capital FidoCure GlobalVetLink Huvepharma Kennelmaster Foods Patterson PetCo (Austria) Pharmgate Saiba Animal Health Three Dog Brands VAFO VetriScience\u00a0 ********************************************* Southwest Veterinary Symposium \u2013 SWVS 2024 JOIN us in Fort Worth! Fort Worth, Texas \u2013 Fort Worth Convention Center September 22-25, 2022 Register TODAY! Southwest Veterinary Symposium \u2014 a partnership of the Arkansas, Louisiana, New Mexico, Oklahoma, and Texas Veterinary Medicine Associations which provides continuing education for veterinary professionals. Join us this September in Fort Worth, Texas, where you can learn about the latest innovations and products while exploring our exhibit hall, network with other veterinary professionals, and choose from more than 400+ hours of quality CE\/RACE-approved sessions.\u00a0 www.swvs.org ************************************** COMPANY NEWS RELEASES Boehringer Ingelheim announced it has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines to address chronic diseases in pets. Saiba Animal Health\u2019s technology platform uses a therapeutic vaccine approach, which is designed to create an immune response, targeting chronic diseases such as allergy, inflammation and pain. Financial terms were not disclosed. (company press release) The FDA announced the approval of Huvepharma&#8216;s CoxidinView Full Post;","thumbnail_url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2023\/06\/Transactions-Logo-300x194.jpg"}